Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 428

1.

Phenotyping and outcomes of hospitalized COPD patients using rapid molecular diagnostics on sputum samples.

Alotaibi NM, Chen V, Hollander Z, Leipsic JA, Hague CJ, Murphy DT, DeMarco ML, FitzGerald JM, McManus BM, Ng RT, Sin DD.

Int J Chron Obstruct Pulmon Dis. 2019 Jan 23;14:311-319. doi: 10.2147/COPD.S188186. eCollection 2019.

PMID:
30774328
2.

Development and Validation of the Evaluation Platform in COPD (EPIC): A Population-Based Outcomes Model of COPD for Canada.

Sadatsafavi M, Ghanbarian S, Adibi A, Johnson K, FitzGerald JM, Flanagan W, Bryan S, Sin D; Canadian Respiratory Research Network.

Med Decis Making. 2019 Feb;39(2):152-167. doi: 10.1177/0272989X18824098. Epub 2019 Jan 24.

PMID:
30678520
3.

Psychological distress is related to poor health behaviours in COPD and non-COPD patients: Evidence from the CanCOLD study.

Paine NJ, Bacon SL, Bourbeau J, Tan WC, Lavoie KL; CanCOLD Study Investigators, Aaron SD, Chapman KR, FitzGerald JM, Hernandez P, Marciniuk DD, Maltais F, O'Donnell DE, Sin D, Walker BL; Canadian Respiratory Research Network and teh CanCOLD Collaborative Research Group.

Respir Med. 2019 Jan;146:1-9. doi: 10.1016/j.rmed.2018.11.006. Epub 2018 Nov 15.

4.

Heterogeneity in the respiratory symptoms of patients with mild-to-moderate COPD.

Johnson KM, Safari A, Tan WC, Bourbeau J, FitzGerald JM, Sadatsafavi M, Study OBOTCCOOLDC; Canadian Respiratory Research Network.

Int J Chron Obstruct Pulmon Dis. 2018 Dec 13;13:3983-3995. doi: 10.2147/COPD.S184424. eCollection 2018.

5.

A systematic review of the adverse events and economic impact associated with oral corticosteroids in asthma.

Al Efraij K, Johnson KM, Wiebe D, Sadatsafavi M, FitzGerald JM.

J Asthma. 2018 Dec 4:1-13. doi: 10.1080/02770903.2018.1539100. [Epub ahead of print]

PMID:
30513226
6.

The Incidence of Recorded Delirium Episodes Before and After Dementia Diagnosis: Differences Between Dementia With Lewy Bodies and Alzheimer's Disease.

FitzGerald JM, Perera G, Chang-Tave A, Price A, Rajkumar AP, Bhattarai M, O'Brien JT, Ballard C, Aarsland D, Stewart R, Mueller C.

J Am Med Dir Assoc. 2018 Nov 15. pii: S1525-8610(18)30532-2. doi: 10.1016/j.jamda.2018.09.021. [Epub ahead of print]

PMID:
30448339
7.

Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial.

Busse WW, Bleecker ER, FitzGerald JM, Ferguson GT, Barker P, Sproule S, Olsson RF, Martin UJ, Goldman M; BORA study investigators.

Lancet Respir Med. 2019 Jan;7(1):46-59. doi: 10.1016/S2213-2600(18)30406-5. Epub 2018 Nov 8. Erratum in: Lancet Respir Med. 2019 Jan;7(1):e1.

PMID:
30416083
8.

Transdiagnostic neural correlates of volitional emotion regulation in anxiety and depression.

Fitzgerald JM, Klumpp H, Langenecker S, Phan KL.

Depress Anxiety. 2018 Nov 8. doi: 10.1002/da.22859. [Epub ahead of print]

PMID:
30408261
9.

Sputum Microbiome is Associated with 1-Year Mortality Following COPD Hospitalizations.

Leitao Filho FS, Alotaibi NM, Ngan D, Tam S, Yang J, Hollander Z, Chen V, FitzGerald JM, Nislow C, Leung JM, Man SFP, Sin DD.

Am J Respir Crit Care Med. 2018 Oct 30. doi: 10.1164/rccm.201806-1135OC. [Epub ahead of print]

PMID:
30376356
10.

Long-term effects of inhaled corticosteroids on bone mineral density in older women with asthma or COPD: a registry-based cohort study.

Chen W, Johnson KM, FitzGerald JM, Sadatsafavi M, Leslie WD.

Arch Osteoporos. 2018 Oct 29;13(1):116. doi: 10.1007/s11657-018-0537-2.

PMID:
30374631
11.

Principal component analysis and brain-based predictors of emotion regulation in anxiety and depression.

Klumpp H, Kinney KL, Bhaumik R, Fitzgerald JM.

Psychol Med. 2018 Oct 25:1-10. doi: 10.1017/S0033291718003148. [Epub ahead of print]

PMID:
30355375
12.

Tiotropium add-on to inhaled corticosteroids versus addition of long-acting β2-agonists for adults with asthma.

Buhl R, FitzGerald JM, Busse WW.

Respir Med. 2018 Oct;143:82-90. doi: 10.1016/j.rmed.2018.08.014. Epub 2018 Aug 29. Review.

13.

Development of the International Severe Asthma Registry (ISAR): A Modified Delphi Study.

Bulathsinhala L, Eleangovan N, Heaney LG, Menzies-Gow A, Gibson PG, Peters M, Hew M, van Boven JFM, Lehtimäki L, van Ganse E, Belhassen M, Harvey ES, Perez de Llano L, Maitland-van der Zee AH, Papadopoulos NG, FitzGerald JM, Porsbjerg C, Canonica GW, Backer V, Rhee CK, Verhamme KMC, Buhl R, Cosio BG, Carter V, Price C, Le T, Stagno d'Alcontres M, Gopalan G, Tran TN, Price D.

J Allergy Clin Immunol Pract. 2019 Feb;7(2):578-588.e2. doi: 10.1016/j.jaip.2018.08.016. Epub 2018 Sep 1.

PMID:
30179741
14.

As-Needed Budesonide-Formoterol in Mild Asthma.

Bateman ED, Reddel HK, FitzGerald JM.

N Engl J Med. 2018 Aug 30;379(9):898. doi: 10.1056/NEJMc1808073. No abstract available.

PMID:
30157403
15.

Neuroimaging Predictors and Mechanisms of Treatment Response in Social Anxiety Disorder: an Overview of the Amygdala.

Klumpp H, Fitzgerald JM.

Curr Psychiatry Rep. 2018 Aug 28;20(10):89. doi: 10.1007/s11920-018-0948-1. Review.

PMID:
30155657
16.

Baseline patient factors impact on the clinical efficacy of benralizumab for severe asthma.

Bleecker ER, Wechsler ME, FitzGerald JM, Menzies-Gow A, Wu Y, Hirsch I, Goldman M, Newbold P, Zangrilli JG.

Eur Respir J. 2018 Oct 18;52(4). pii: 1800936. doi: 10.1183/13993003.00936-2018. Print 2018 Oct.

17.

A pilot randomized controlled trial on the impact of text messaging check-ins and a web-based asthma action plan versus a written action plan on asthma exacerbations.

Poureslami I PhD, Shum J MSc, Lester RT MD, Tavakoli H MD, MSc, Dorscheid DR MD, PhD, FitzGerald JM MD.

J Asthma. 2018 Oct 16:1-13. doi: 10.1080/02770903.2018.1500583. [Epub ahead of print]

PMID:
30003851
18.

Benralizumab for the add-on maintenance treatment of patients with severe asthma aged 12 years and older with an eosinophilic phenotype.

Al Efraij K, FitzGerald JM.

Expert Rev Clin Pharmacol. 2018 Jul;11(7):669-676. doi: 10.1080/17512433.2018.1496819. Epub 2018 Jul 11. Review.

PMID:
29972739
19.

Between-Visit Variability in FEV1 as a Diagnostic Test for Asthma in Adults.

Dean BW, Birnie EE, Whitmore GA, Vandemheen KL, Boulet LP, FitzGerald JM, Ainslie M, Gupta S, Lemiere C, Field SK, McIvor RA, Hernandez P, Mayers I, Aaron SD; Canadian Respiratory Research Network.

Ann Am Thorac Soc. 2018 Sep;15(9):1039-1046. doi: 10.1513/AnnalsATS.201803-211OC.

PMID:
29877740
20.

Working Memory Load and Negative Picture Processing: Neural and Behavioral Associations With Panic, Social Anxiety, and Positive Affect.

MacNamara A, Jackson TB, Fitzgerald JM, Hajcak G, Phan KL.

Biol Psychiatry Cogn Neurosci Neuroimaging. 2019 Feb;4(2):151-159. doi: 10.1016/j.bpsc.2018.04.005. Epub 2018 Apr 22.

PMID:
29805056
21.

Effect of tralokinumab, an interleukin-13 neutralising monoclonal antibody, on eosinophilic airway inflammation in uncontrolled moderate-to-severe asthma (MESOS): a multicentre, double-blind, randomised, placebo-controlled phase 2 trial.

Russell RJ, Chachi L, FitzGerald JM, Backer V, Olivenstein R, Titlestad IL, Ulrik CS, Harrison T, Singh D, Chaudhuri R, Leaker B, McGarvey L, Siddiqui S, Wang M, Braddock M, Nordenmark LH, Cohen D, Parikh H, Colice G, Brightling CE; MESOS study investigators.

Lancet Respir Med. 2018 Jul;6(7):499-510. doi: 10.1016/S2213-2600(18)30201-7. Epub 2018 May 21.

PMID:
29793857
22.

Health literacy in chronic disease management: a matter of interaction.

van der Heide I, Poureslami I, Mitic W, Shum J, Rootman I, FitzGerald JM.

J Clin Epidemiol. 2018 Oct;102:134-138. doi: 10.1016/j.jclinepi.2018.05.010. Epub 2018 May 21.

PMID:
29793001
23.

Inhaled Glucocorticoids in Asthma.

Boulet LP, Gupta S, FitzGerald JM.

N Engl J Med. 2018 May 24;378(21):2050-1. doi: 10.1056/NEJMc1804801. No abstract available.

PMID:
29792407
24.

Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma.

Castro M, Corren J, Pavord ID, Maspero J, Wenzel S, Rabe KF, Busse WW, Ford L, Sher L, FitzGerald JM, Katelaris C, Tohda Y, Zhang B, Staudinger H, Pirozzi G, Amin N, Ruddy M, Akinlade B, Khan A, Chao J, Martincova R, Graham NMH, Hamilton JD, Swanson BN, Stahl N, Yancopoulos GD, Teper A.

N Engl J Med. 2018 Jun 28;378(26):2486-2496. doi: 10.1056/NEJMoa1804092. Epub 2018 May 21.

25.

Asthma in low-income and middle-income countries: an urgent call to action.

FitzGerald JM, Al Efraij K.

Thorax. 2018 Oct;73(10):898-899. doi: 10.1136/thoraxjnl-2018-211718. Epub 2018 May 18. No abstract available.

PMID:
29777061
26.

Inhaled Combined Budesonide-Formoterol as Needed in Mild Asthma.

O'Byrne PM, FitzGerald JM, Bateman ED, Barnes PJ, Zhong N, Keen C, Jorup C, Lamarca R, Ivanov S, Reddel HK.

N Engl J Med. 2018 May 17;378(20):1865-1876. doi: 10.1056/NEJMoa1715274.

27.

As-Needed Budesonide-Formoterol versus Maintenance Budesonide in Mild Asthma.

Bateman ED, Reddel HK, O'Byrne PM, Barnes PJ, Zhong N, Keen C, Jorup C, Lamarca R, Siwek-Posluszna A, FitzGerald JM.

N Engl J Med. 2018 May 17;378(20):1877-1887. doi: 10.1056/NEJMoa1715275.

28.

Long-Term Trajectories of Mild Asthma in Adulthood and Risk Factors of Progression.

Chen W, FitzGerald JM, Lynd LD, Sin DD, Sadatsafavi M.

J Allergy Clin Immunol Pract. 2018 Nov - Dec;6(6):2024-2032.e5. doi: 10.1016/j.jaip.2018.04.027. Epub 2018 May 7.

PMID:
29746917
29.

Functional Neuroanatomy of Emotion and Its Regulation in PTSD.

Fitzgerald JM, DiGangi JA, Phan KL.

Harv Rev Psychiatry. 2018 May/Jun;26(3):116-128. doi: 10.1097/HRP.0000000000000185.

PMID:
29734226
30.

The projected economic and health burden of sub-optimal asthma control in Canada.

Zafari Z, Sadatsafavi M, Chen W, FitzGerald JM.

Respir Med. 2018 May;138:7-12. doi: 10.1016/j.rmed.2018.03.018. Epub 2018 Mar 16.

PMID:
29724396
31.

The Impact of Care Specialty on Survival-Adjusted Medical Costs of COPD Patients After a Hospitalization: a longitudinal analysis.

Chen W, Sin DD, FitzGerald JM, Sadatsafavi M; Canadian Respiratory Research Network.

J Gen Intern Med. 2018 Sep;33(9):1528-1535. doi: 10.1007/s11606-018-4406-x. Epub 2018 Apr 2.

PMID:
29611088
32.

Distinct neural engagement during implicit and explicit regulation of negative stimuli.

Fitzgerald JM, Kinney KL, Phan KL, Klumpp H.

Neuropsychologia. 2018 Feb 8. pii: S0028-3932(18)30059-9. doi: 10.1016/j.neuropsychologia.2018.02.002. [Epub ahead of print]

PMID:
29428771
33.

The effects of a CCR3 inhibitor, AXP1275, on allergen-induced airway responses in adults with mild-to-moderate atopic asthma.

Gauvreau GM, FitzGerald JM, Boulet LP, Watson RM, Hui L, Villineuve H, Scime TX, Schlatman AR, Obminski C, Kum J, Boehme S, Ly TW, Bacon KB, O'Byrne PM.

Clin Exp Allergy. 2018 Apr;48(4):445-451. doi: 10.1111/cea.13114. Epub 2018 Mar 13.

PMID:
29423947
34.

Phenotyping COPD exacerbations using imaging and blood-based biomarkers.

Alotaibi NM, Chen V, Hollander Z, Hague CJ, Murphy DT, Leipsic JA, DeMarco ML, FitzGerald JM, McManus BM, Ng RT, Sin DD.

Int J Chron Obstruct Pulmon Dis. 2018 Jan 8;13:217-229. doi: 10.2147/COPD.S152484. eCollection 2018.

35.

The association between previous and future severe exacerbations of chronic obstructive pulmonary disease: Updating the literature using robust statistical methodology.

Sadatsafavi M, Xie H, Etminan M, Johnson K, FitzGerald JM; Canadian Respiratory Research Network.

PLoS One. 2018 Jan 19;13(1):e0191243. doi: 10.1371/journal.pone.0191243. eCollection 2018.

36.

Delirium and the acute hospital system of the Republic of Ireland: Challenges, solutions and opportunities.

Fitzgerald JM.

Ir Med J. 2017 Aug 8;110(7):596. No abstract available.

PMID:
29341508
37.

A randomised clinical trial of feedback on inhaler adherence and technique in patients with severe uncontrolled asthma.

Sulaiman I, Greene G, MacHale E, Seheult J, Mokoka M, D'Arcy S, Taylor T, Murphy DM, Hunt E, Lane SJ, Diette GB, FitzGerald JM, Boland F, Sartini Bhreathnach A, Cushen B, Reilly RB, Doyle F, Costello RW.

Eur Respir J. 2018 Jan 4;51(1). pii: 1701126. doi: 10.1183/13993003.01126-2017. Print 2018 Jan.

PMID:
29301919
38.

Neural indices of emotional reactivity and regulation predict course of PTSD symptoms in combat-exposed veterans.

Fitzgerald JM, Gorka SM, Kujawa A, DiGangi JA, Proescher E, Greenstein JE, Aase DM, Schroth C, Afshar K, Kennedy AE, Hajcak G, Phan KL.

Prog Neuropsychopharmacol Biol Psychiatry. 2018 Mar 2;82:255-262. doi: 10.1016/j.pnpbp.2017.11.005. Epub 2017 Nov 7.

PMID:
29122638
39.

Airway diseases and health literacy (HL) measurement tools: A systematic review to inform respiratory research and practice.

Shum J, Poureslami I, Wiebe D, Doyle-Waters MM, Nimmon L, FitzGerald JM; Canadian Airways Health Literacy Study Group.

Patient Educ Couns. 2018 Apr;101(4):596-618. doi: 10.1016/j.pec.2017.10.011. Epub 2017 Oct 27. Review.

PMID:
29107399
40.

Novel Blood-based Transcriptional Biomarker Panels Predict the Late-Phase Asthmatic Response.

Singh A, Shannon CP, Kim YW, Yang CX, Balshaw R, Cohen Freue GV, Gauvreau GM, FitzGerald JM, Boulet LP, O'Byrne PM, Tebbutt SJ.

Am J Respir Crit Care Med. 2018 Feb 15;197(4):450-462. doi: 10.1164/rccm.201701-0110OC.

PMID:
29087730
41.

Principal component analysis and neural predictors of emotion regulation.

Klumpp H, Bhaumik R, Kinney KL, Fitzgerald JM.

Behav Brain Res. 2018 Feb 15;338:128-133. doi: 10.1016/j.bbr.2017.10.024. Epub 2017 Oct 20.

42.

Crowdfunding for respiratory research: a new frontier for patient and public engagement?

Wiebe DP, FitzGerald JM.

Eur Respir J. 2017 Oct 5;50(4). pii: 1701333. doi: 10.1183/13993003.01333-2017. Print 2017 Oct. No abstract available.

PMID:
28982767
43.

Inhaled Steroids and Active Smoking Drive Chronic Obstructive Pulmonary Disease Symptoms and Biomarkers to a Greater Degree Than Airflow Limitation.

Silkoff PE, Singh D, FitzGerald JM, Eich A, Ludwig-Sengpiel A, Chupp GC, Backer V, Porsbjerg C, Girodet PO, Dransfield MT, Baribaud F, Susulic VS, Loza MJ.

Biomark Insights. 2017 Sep 7;12:1177271917730306. doi: 10.1177/1177271917730306. eCollection 2017.

44.

The impact of inappropriate use of short acting beta agonists in asthma.

FitzGerald JM, Tavakoli H, Lynd LD, Al Efraij K, Sadatsafavi M.

Respir Med. 2017 Oct;131:135-140. doi: 10.1016/j.rmed.2017.08.014. Epub 2017 Aug 17.

PMID:
28947020
45.

Predictors of enhanced response with benralizumab for patients with severe asthma: pooled analysis of the SIROCCO and CALIMA studies.

FitzGerald JM, Bleecker ER, Menzies-Gow A, Zangrilli JG, Hirsch I, Metcalfe P, Newbold P, Goldman M.

Lancet Respir Med. 2018 Jan;6(1):51-64. doi: 10.1016/S2213-2600(17)30344-2. Epub 2017 Sep 11.

PMID:
28919200
46.

Work productivity loss in mild to moderate COPD: lessons learned from the CanCOLD study.

de Sousa Sena R, Ahmed S, Tan WC, Li PZ, Labonté L, Aaron SD, Benedetti A, Chapman KR, Walker B, Fitzgerald JM, Hernandez P, Maltais F, Marciniuk DD, O'Donnell DE, Sin DD, Bourbeau J; CanCOLD Collaborative Research Group and The Canadian Respiratory Research Network.

Eur Respir J. 2017 Sep 12;50(3). pii: 1701154. doi: 10.1183/13993003.01154-2017. Print 2017 Sep. No abstract available.

PMID:
28899939
47.

Global Initiative for Chronic Obstructive Lung Disease 2017 Classification and Lung Function Decline in Chronic Obstructive Pulmonary Disease.

Tan WC, Bourbeau J, Aaron SD, Zhou G, Maltais F, Hernandez P, Fitzgerald JM, Marciniuk DD, Walker BL, Sin DD.

Am J Respir Crit Care Med. 2018 Mar 1;197(5):670-673. doi: 10.1164/rccm.201706-1154LE. No abstract available.

PMID:
28858570
48.

Emerging interleukin receptor antagonists for the treatment of asthma.

Al Efraij K, FitzGerald JM.

Expert Opin Emerg Drugs. 2017 Sep;22(3):275-283. doi: 10.1080/14728214.2017.1369954. Epub 2017 Aug 23. Review.

PMID:
28832218
49.

Excess economic burden of comorbidities in COPD: a 15-year population-based study.

Chen W, FitzGerald JM, Sin DD, Sadatsafavi M; Canadian Respiratory Research Network.

Eur Respir J. 2017 Jul 27;50(1). pii: 1700393. doi: 10.1183/13993003.00393-2017. Print 2017 Jul.

50.

Testing the External Validity of a Discrete Choice Experiment Method: An Application to Latent Tuberculosis Infection Treatment.

Mohammadi T, Bansback N, Marra F, Khakban A, Campbell JR, FitzGerald JM, Lynd LD, Marra CA.

Value Health. 2017 Jul - Aug;20(7):969-975. doi: 10.1016/j.jval.2017.04.007. Epub 2017 May 19.

Supplemental Content

Loading ...
Support Center